Fortis Healthcare Limited has issued a comprehensive postal ballot notice to shareholders seeking approval for its new Employee Stock Option Scheme 2026, marking a significant step in the company's talent retention and incentivization strategy.

Postal Ballot Notice Details

The company sent the postal ballot notice on February 16, 2026, to all shareholders in compliance with Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. The notice seeks shareholder approval through special resolutions for three interconnected proposals related to the ESOP 2026 implementation.

Employee Stock Option Scheme 2026 Framework

The proposed ESOP 2026 represents a comprehensive employee incentivization program designed to attract and retain high-quality talent while aligning employee interests with shareholder value creation. The scheme covers eligible employees across the company, its subsidiaries, and associate companies.

Key Scheme Features

Three Special Resolutions for Approval

The postal ballot seeks approval for three distinct but related special resolutions:

Resolution 1: Approval of the Fortis Healthcare Limited Employee Stock Option Scheme 2026 for the company's direct employees and directors (excluding promoters, promoter group members, independent directors, and those holding more than 10% equity).

Resolution 2: Authorization to grant stock options to eligible employees of subsidiary companies under the same scheme framework.

Resolution 3: Authorization to grant stock options to eligible employees of associate companies under the ESOP 2026.

Eligibility and Implementation Structure

The scheme encompasses employees working exclusively with the company, subsidiaries, or associates, whether in India or internationally. The eligibility framework specifically excludes promoters, promoter group members, independent directors, and directors holding more than 10% of outstanding equity shares.

The Nomination and Remuneration Committee, designated as the Compensation Committee, will administer the scheme in accordance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. The committee approved the ESOP 2026 on February 11, 2026, followed by Board approval on February 13, 2026.

Voting Process and Timeline

Shareholders can participate through remote e-voting facilitated by KFin Technologies Limited or traditional postal ballot forms. The company emphasizes that shareholders can use only one voting mode, with e-voting taking precedence if both methods are used.

The voting process accommodates both demat and physical shareholding modes, with detailed instructions provided for accessing various depository platforms including NSDL and CDSL systems.

Strategic Rationale

According to the explanatory statement, the company demonstrated commendable financial performance with robust revenue growth and improved profitability metrics. The ESOP 2026 aims to maintain competitiveness in the talent market while driving high-performance culture through equity participation aligned with long-term business objectives.

The scheme builds upon the company's previous employee stock option plans from 2007 and 2011, reflecting continued commitment to employee ownership and retention strategies.

Source:

Fortis Healthcare Limited has formally notified stock exchanges about comprehensive arrangements for its quarterly financial performance review. The healthcare major will present its third-quarter results to investors and stakeholders through multiple engagement channels following regulatory compliance procedures.

Board Meeting Details

The company has scheduled a Board of Directors meeting for Friday, February 13, 2026, with a specific agenda to consider and approve crucial financial documents. The meeting will focus on reviewing comprehensive financial performance across different business segments.

Conference Call Schedule

Following the board meeting, Fortis Healthcare Limited has arranged a conference call to discuss the financial results with investors and analysts. The virtual meeting will provide detailed insights into the company's quarterly and nine-month performance.

Dial-in Information

The company has provided comprehensive dial-in details for both domestic and international participants to ensure broad accessibility for the conference call.

Trading Window Restrictions

In accordance with regulatory compliance requirements, Fortis Healthcare Limited has implemented mandatory trading restrictions for company securities. The trading window closure ensures fair market practices during the financial results announcement period.

Regulatory Compliance

The board meeting and conference call notifications have been issued in strict compliance with Securities and Exchange Board of India regulations. The company has fulfilled its disclosure obligations under multiple regulatory frameworks to ensure transparency in corporate governance. The notifications were filed under Regulation 29, 30, and 50 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.